Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients
Guowei Li, Deborah J Cook, Mitchell AH Levine, Gordon Guyatt, Mark Crowther, Diane Heels-Ansdell, Anne Holbrook, Francois Lamontagne, Stephen D Walter, Niall D Ferguson, Simon Finfer, Yaseen M Arabi, Rinaldo Bellomo, D Jamie Cooper, Lehana Thabane
Medicine | LIPPINCOTT WILLIAMS & WILKINS | Published : 2015
Awarded by Canadian Institutes of Health Research (CIHR)
Awarded by Australian and New Zealand College of Anesthetists Research Foundation
Awarded by Heart and Stroke Foundation of Canada
PROTECT was funded by the Canadian Institutes of Health Research (CIHR, #MCT78568), the Australian and New Zealand College of Anesthetists Research Foundation (#07/23), and the Heart and Stroke Foundation of Canada (#T6157, #T6950, #NA6186). Mr Li receives a Father Sean O'Sullivan Research Award, the Research Institute of St. Joe's Hamilton, and a doctoral award from the China Scholarship Council. Dr Cook is a research chair of the CIHR. Dr Crowther holds a Career Investigator Award from the Heart and Stroke Foundation of Ontario and the Leo Pharma Chair in Thromboembolism Research at McMaster University and St Joseph's Healthcare, Hamilton. Dr Crowther sits on advisory boards for Leo Pharma Inc; Pfizer, Inc; Bayer; Boehringer-Ingelheim GmbH; Alexion; CSL Behring; and Artisan Pharma, Inc. He also prepares educational materials for Pfizer, Octapharma, and CSL Behring, and provides expert testimony for Bayer. Dr Lamontagne is a recipient of a research career award from the FRQ-S and a CIHR RCT Mentoring Award.